Matches in SemOpenAlex for { <https://semopenalex.org/work/W3185703391> ?p ?o ?g. }
- W3185703391 endingPage "1168" @default.
- W3185703391 startingPage "1168" @default.
- W3185703391 abstract "A possibility of repurposing sitagliptin, a well-established antidiabetic drug, for alleviating injury caused by ischemia-reperfusion (IR) is being researched. The aim of this study was to shed some light on the molecular background of the protective activity of sitagliptin during hepatic IR. The expression and/or concentration of inflammation and oxidative stress-involved factors have been determined in rat liver homogenates using quantitative RT-PCR and Luminex® xMAP® technology and markers of nitrative and halogenative stress were quantified using targeted metabolomics (LC-MS/MS). Animals (n = 36) divided into four groups were treated with sitagliptin (5 mg/kg) (S and SIR) or saline solution (C and IR), and the livers from IR and SIR were subjected to ischemia (60 min) and reperfusion (24 h). The midkine expression (by 2.2-fold) and the free 3-nitrotyrosine (by 2.5-fold) and IL-10 (by 2-fold) concentration were significantly higher and the Nox4 expression was lower (by 9.4-fold) in the IR than the C animals. As compared to IR, the SIR animals had a lower expression of interleukin-6 (by 4.2-fold) and midkine (by 2-fold), a lower concentration of 3-nitrotyrosine (by 2.5-fold) and a higher Nox4 (by 2.9-fold) and 3-bromotyrosine (by 1.4-fold). In conclusion, IR disturbs the oxidative, nitrative and halogenative balance and aggravates the inflammatory response in the liver, which can be attenuated by low doses of sitagliptin." @default.
- W3185703391 created "2021-08-02" @default.
- W3185703391 creator A5010522343 @default.
- W3185703391 creator A5019370534 @default.
- W3185703391 creator A5035145585 @default.
- W3185703391 creator A5061854001 @default.
- W3185703391 creator A5073253235 @default.
- W3185703391 creator A5075232026 @default.
- W3185703391 creator A5079488833 @default.
- W3185703391 creator A5086718568 @default.
- W3185703391 date "2021-07-22" @default.
- W3185703391 modified "2023-10-16" @default.
- W3185703391 title "Sitagliptin Modulates Oxidative, Nitrative and Halogenative Stress and Inflammatory Response in Rat Model of Hepatic Ischemia-Reperfusion" @default.
- W3185703391 cites W1936557532 @default.
- W3185703391 cites W1963847375 @default.
- W3185703391 cites W1980624836 @default.
- W3185703391 cites W2002169255 @default.
- W3185703391 cites W2003362156 @default.
- W3185703391 cites W2015935391 @default.
- W3185703391 cites W2030253244 @default.
- W3185703391 cites W2055000746 @default.
- W3185703391 cites W2059572472 @default.
- W3185703391 cites W2060149822 @default.
- W3185703391 cites W2061063914 @default.
- W3185703391 cites W2065399019 @default.
- W3185703391 cites W2069393668 @default.
- W3185703391 cites W2075034126 @default.
- W3185703391 cites W2089375797 @default.
- W3185703391 cites W2092522316 @default.
- W3185703391 cites W2095187118 @default.
- W3185703391 cites W2109907166 @default.
- W3185703391 cites W2115197476 @default.
- W3185703391 cites W2118974930 @default.
- W3185703391 cites W2120575234 @default.
- W3185703391 cites W2131821161 @default.
- W3185703391 cites W2141131740 @default.
- W3185703391 cites W2147947221 @default.
- W3185703391 cites W2161606388 @default.
- W3185703391 cites W2163309283 @default.
- W3185703391 cites W2164875000 @default.
- W3185703391 cites W2168540880 @default.
- W3185703391 cites W2395970505 @default.
- W3185703391 cites W2501946307 @default.
- W3185703391 cites W2574778880 @default.
- W3185703391 cites W2598265081 @default.
- W3185703391 cites W2599436748 @default.
- W3185703391 cites W2690065025 @default.
- W3185703391 cites W2740040187 @default.
- W3185703391 cites W2751939039 @default.
- W3185703391 cites W2883704382 @default.
- W3185703391 cites W2887608221 @default.
- W3185703391 cites W2891241173 @default.
- W3185703391 cites W2896002881 @default.
- W3185703391 cites W2896072709 @default.
- W3185703391 cites W2896632039 @default.
- W3185703391 cites W2896880451 @default.
- W3185703391 cites W2898606740 @default.
- W3185703391 cites W2904747301 @default.
- W3185703391 cites W2909293124 @default.
- W3185703391 cites W2912735280 @default.
- W3185703391 cites W2946078715 @default.
- W3185703391 cites W2952096541 @default.
- W3185703391 cites W2970374381 @default.
- W3185703391 cites W2973993463 @default.
- W3185703391 cites W2975430167 @default.
- W3185703391 cites W2985345894 @default.
- W3185703391 cites W2988235176 @default.
- W3185703391 cites W2990297874 @default.
- W3185703391 cites W2994037018 @default.
- W3185703391 cites W2997440292 @default.
- W3185703391 cites W3005979413 @default.
- W3185703391 cites W3006850512 @default.
- W3185703391 cites W3037578381 @default.
- W3185703391 cites W3038503389 @default.
- W3185703391 cites W3045225630 @default.
- W3185703391 cites W3086191746 @default.
- W3185703391 cites W3096983190 @default.
- W3185703391 cites W3115051279 @default.
- W3185703391 cites W3122008314 @default.
- W3185703391 cites W3127032693 @default.
- W3185703391 cites W3127338671 @default.
- W3185703391 cites W3134913471 @default.
- W3185703391 cites W3162176594 @default.
- W3185703391 cites W3176210726 @default.
- W3185703391 doi "https://doi.org/10.3390/antiox10081168" @default.
- W3185703391 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8388898" @default.
- W3185703391 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34439416" @default.
- W3185703391 hasPublicationYear "2021" @default.
- W3185703391 type Work @default.
- W3185703391 sameAs 3185703391 @default.
- W3185703391 citedByCount "7" @default.
- W3185703391 countsByYear W31857033912021 @default.
- W3185703391 countsByYear W31857033912022 @default.
- W3185703391 countsByYear W31857033912023 @default.
- W3185703391 crossrefType "journal-article" @default.
- W3185703391 hasAuthorship W3185703391A5010522343 @default.
- W3185703391 hasAuthorship W3185703391A5019370534 @default.
- W3185703391 hasAuthorship W3185703391A5035145585 @default.